Speaker illustration

Doctor Hiroaki Matsuda

Nagoya Heart Center, Nagoya (Japan)

Mid-term clinical outcomes of biodegradable polymer everolimus-eluting stents compared with durable polymer everolimus-eluting stents: a propensity-matched study

Event: ESC Asia with APSC & AFC

Topic: Stents

Session: Poster Session Sunday


Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Event: ESC Congress 2019

Topic: Stents

Session: Percutaneous coronary syndrome: pharma and devices


Qualitative and quantitative comparison of the neointima between bare-metal stents and sirolimus-eluting stents in the very late phase (>7 years); analysis by optimal frequency domain imaging

Event: ESC Congress 2017

Topic: Restenosis

Session: PCI - Restenosis


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb